DantePieramiciMD
Ophthalmology • Santa Barbara, CARetinal Disease
Director California Retina Research Foundation
Dr. Pieramici is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E Micheltorena St
Ste A
Santa Barbara, CA 93103Phone+1 805-963-1648Fax+1 661-322-8489
Summary
- Dr. Dante Pieramici is an ophthalmologist in Santa Barbara, CA and is affiliated with multiple hospitals in the area, including Community Memorial Hospital, Goleta Valley Cottage Hospital, Providence Saint John's Health Center, and Santa Barbara Cottage Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 26 years. He specializes in retinal disease and is experienced in retina surgery, general / comprehensive ophthalmology, vitreoretinal disease, and pediatric retinal disease.
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 1992 - 1995
University of Chicago (NorthShore)Internship, Transitional Year, 1991 - 1992- Johns Hopkins University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 2001 - 2026
MD State Medical License 1996 - 2005
CT State Medical License 1997 - 1998
GA State Medical License 1995 - 1997- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Lucentis for Central Retinal Vein Occlusion (CRVO) Start of enrollment: 2006 Jan 01
- Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) Start of enrollment: 2006 May 01
- Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 143 citationsSubretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments TrialsAlex S. Willoughby, Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell Burns
Ophthalmology. 2015-09-01 - 2 citationsInfliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.Shiri Zayit-Soudry, Igor Vainer, Esther Zemel, Michael Mimouni, Melvin Rabena
Documenta Ophthalmologica. Advances in Ophthalmology. 2017-08-19 - 106 citationsIncidence and rate of disappearance of retinal hemorrhage in newborns.M.Vaughn Emerson, Dante J. Pieramici, Kathleen M. Stoessel, John P Berreen, Ray F. Gariano
Ophthalmology. 2001-01-01
Authored Content
- The Port Delivery System with RanibizumabMarch 2019
Press Mentions
Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-Vec (ADVM-022) in the OPTIC Study in Wet AMDOctober 1st, 2022
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
The Port Delivery System with RanibizumabMarch 1st, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
